Annaly Capital Management, Inc. vs 10X Genomics Inc — how do they compare? Annaly Capital Management, Inc. trades at $23.18 (market cap $17.44B), while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: Annaly Capital Management, Inc. is far larger — about 2.3× 10X Genomics Inc's market cap, and Annaly Capital Management, Inc. pays a 12.96% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| NLY | TXG | |
|---|---|---|
Market Cap | $17.44B | $7.61B |
Sector | Financials | Health |
52-Week High | $24.40 | $58.57 |
52-Week Low | $20.21 | $11.34 |
Dividend Yield | 12.96% | — |
Enterprise Value | — | $7.14B |
Trailing returns across standard periods
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →